TLR2 and breast carcinoma: TLR2 expression is particularly high in breast cancer cell lines endowed with metastatic potential, and its activation induces invasiveness through the secretion of IL-6, TGF-β, VEGF, and the metalloproteinase (MMP)9, which degrades the extracellular matrix [66].